Clinical use of Haemate(R) P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

Abstract

Based on this retrospective study conducted in a large cohort of Italian patients (n=100) and covering a long period of observation (36 months), Haemate P was shown to be effective and safe for the clinical management of patients with VWD, whether given on demand or as prophylaxis.